Phibro Animal Health (PAHC) Earnings Analysis

Phibro Animal Health (PAHC) next reports earnings on 2026-08-26, consensus EPS 0.72 USD. Last quarter (2026-02-04) it beat with EPS 0.87 USD vs 0.69 USD est (+26.1%). It has beaten estimates in 5/5 recent quarters (100%). Trailing P/E 14.45.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does PAHC next report earnings?

Next earnings date2026-08-26
Consensus EPS estimate0.72 USD
Revenue estimate0.38B

PAHC earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-040.87 USD0.69 USD+26.1%Beat
2025-08-270.57 USD0.52 USD+9.6%Beat
2025-02-050.54 USD0.4 USD+35%Beat
2024-11-070.35 USD0.25 USD+40%Beat
2024-08-280.41 USD0.34 USD+20.6%Beat

Beat rate: 5/5 (100%) over reported quarters with consensus data.

PAHC valuation and analyst view

Trailing P/E14.45
Trailing EPS2.348 USD
Price / book3.79
Dividend yield1.42%
Market cap1.38B
Analyst consensusBuy (6 buy / 4 hold / 4 sell)
Avg price target41.5 USD

Related research pages

Frequently asked questions

When is Phibro Animal Health (PAHC)'s next earnings date?

Phibro Animal Health is next scheduled to report on 2026-08-26, with a consensus EPS estimate of 0.72 USD and revenue estimate of 0.38B.

Did PAHC beat earnings last quarter?

In its 2026-02-04 report, PAHC posted EPS of 0.87 USD versus a 0.69 USD estimate — a beat of 26.1%.

What is PAHC's earnings track record?

Over the last 5 reported quarters with consensus data, PAHC beat estimates 5 times (100%).

What is PAHC's current P/E ratio and EPS?

PAHC trades at a trailing P/E of 14.45 on trailing EPS of 2.348499420482849 USD.

What do analysts rate PAHC?

Analyst consensus is "Buy" across 14 ratings (0 strong buy, 6 buy, 4 hold, 4 sell, 0 strong sell). Average 12-month price target: 41.5 USD.